Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Chief Scientific Officer of $IVVD Sells 18,189 Shares

Automated

Robert D. III Allen, the Chief Scientific Officer of $IVVD, sold 18,189 shares of the company on 02-17-2026 for an estimated $28,003. We received data on the trade from a recent SEC filing. This was a sale of approximately 12.0% of their shares of this class of stock. Following this trade, they now own 133,879 shares of this class of $IVVD stock.

$IVVD Insider Trading Activity

IVVD Insider Trades

$IVVD insiders have traded $IVVD stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $IVVD stock by insiders over the last 6 months:

  • KEVIN F MCLAUGHLIN purchased 50,000 shares for an estimated $125,000
  • JILL ANDERSEN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 67,710 shares for an estimated $105,580.
  • WILLIAM E. DUKE (Chief Financial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
  • JULIE GREEN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
  • TIMOTHY EDWARD LEE (Chief Commercial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
  • ROBERT D. III ALLEN (Chief Scientific Officer) has made 0 purchases and 2 sales selling 37,581 shares for an estimated $58,600.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IVVD Hedge Fund Activity

We have seen 73 institutional investors add shares of $IVVD stock to their portfolio, and 40 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$IVVD Analyst Ratings

Wall Street analysts have issued reports on $IVVD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 12/23/2025
  • HC Wainwright & Co. issued a "Buy" rating on 11/03/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 10/06/2025

To track analyst ratings and price targets for $IVVD, check out Quiver Quantitative's $IVVD forecast page.

$IVVD Price Targets

Multiple analysts have issued price targets for $IVVD recently. We have seen 4 analysts offer price targets for $IVVD in the last 6 months, with a median target of $10.0.

Here are some recent targets:

  • Thomas Shrader from BTIG set a target price of $10.0 on 12/23/2025
  • Patrick R. Trucchio from HC Wainwright & Co. set a target price of $10.0 on 11/03/2025
  • Josh Schimmer from Cantor Fitzgerald set a target price of $10.0 on 10/06/2025
  • Jason Kolbert from D. Boral Capital set a target price of $2.0 on 10/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles